Policies to reform the ability of benefit managers to profit from medication list prices and rectify misaligned incentives that lead to increased patient costs are critical to address their predatory role in our health system. Without action to advance proposals that would help patients better access the medicines they need, patients in Illinois and across the country will continue to be subject to pharmacy benefit managers’ “profit over patients” model. In the new year, Congress must act on reform.
Biden-Harris must ensure access to HIV prevention drugs
The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are hitting the market, but insurance companies are trying to twist the rules to deny access to these remarkable therapies. The White House could stop these abuses and put the country on the right course for decades ahead and prevent hundreds of thousands of new HIV transmissions.
Administration Must End Prescription Drug Insurance Scheme
If the administration does not act, patients nationwide will continue to be subject to schemes that lead to higher out-of-pocket costs for the medications they need, risking medical debt or facing treatment delays and lack of adherence. To protect patients, essential health benefits drugs must be rightfully treated with the gravity that their name implies—medications that are “essential” to a healthy life for patients.
The Biden-Harris administration must side with patients against big insurers’ illegal greed
For years, greedy insurers and PBMs, who have been in the news lately, have used copay accumulators and other nefarious tactics to inflate patient costs and increase their profits. It’s time for President Biden, Vice President Harris, and Secretary Becerra to do something about it.
Congress must not miss an opportunity to end HIV
Despite the Republican-led success against HIV, some House Republicans have been considering a spending bill that would cut funding for HIV prevention and treatment. Such cuts would not only lead to more preventable infections and deaths — they’d result in more long-term spending by American taxpayers. We have the tools to end HIV. We must not abandon our efforts nor the people and communities most impacted by this potentially deadly infectious disease.